Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma
C. Domenge(Institut Gustave Roussy), B Luboïnski(Institut Gustave Roussy), Catherine Hill(Institut Gustave Roussy), H Sancho-Garnier(Institut Gustave Roussy), Bernard Coche‐Dequeant(Centre Oscar Lambret), P Marandas(Institut Gustave Roussy), D. De Raucourt(Centre Hospitalier Universitaire de Nantes), Jean Louis Lefèbvre(Centre Oscar Lambret), M Stromboni-Luboinski(Institut Gustave Roussy), P. Wibault(Institut Gustave Roussy), B. Rhein(Centre Hospitalier Universitaire de Limoges)
Cited by 253
Related Papers
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial
|JNCI Journal of the National Cancer Institute|1996|1.3k
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks
|Radiation Research|2007|678
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries
|BMJ|2005|600
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study
|Journal of Clinical Oncology|2013|418